Cannabinoids: for better and for worse .

IF 8.3 2区医学 Q1 Medicine

Dialogues in Clinical Neuroscience Pub Date : 2020-09-01 DOI:10.31887/DCNS.2020.22.3/fthibaut

Florence Thibaut, Margret R Hoehe

引用次数: 4

Abstract

The use of cannabis as a drug has undergone a remarkable change of direction: considered as a symbol of countercultures in past decades, it is presently being hailed as a cure for any number of diseases and conditions. Thus, despite concerns about the safety of cannabis and cannabinoids, quite a few drugs that contain cannabinoids have recently been approved by several drug agencies, and the medicinal and recreational use of cannabis has been legalized in various countries and states. The promise of cannabinoids for therapeutic use, as well as potentially detrimental health risks and regulatory issues, will need to be carefully weighed. .

查看原文本刊更多论文

大麻素:是好是坏 。

大麻作为一种药物的使用经历了一个显著的方向变化:在过去的几十年里，它被认为是反主流文化的象征，而现在它被誉为治疗许多疾病和病症的良药。因此，尽管人们对大麻和大麻素的安全性感到担忧，但最近几家药物机构批准了相当多含有大麻素的药物，并且大麻的医疗和娱乐用途已在许多国家和州合法化。大麻素用于治疗用途的前景，以及潜在的有害健康风险和监管问题，都需要仔细权衡。 。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Dialogues in Clinical Neuroscience Medicine-Psychiatry and Mental Health

CiteScore

19.30

自引率

1.20%

发文量

期刊介绍： Dialogues in Clinical Neuroscience (DCNS) endeavors to bridge the gap between clinical neuropsychiatry and the neurosciences by offering state-of-the-art information and original insights into pertinent clinical, biological, and therapeutic aspects. As an open access journal, DCNS ensures accessibility to its content for all interested parties. Each issue is curated to include expert reviews, original articles, and brief reports, carefully selected to offer a comprehensive understanding of the evolving landscape in clinical neuroscience. Join us in advancing knowledge and fostering dialogue in this dynamic field.

Cannabinoids: for better and for worse .

Abstract

Cannabinoids: for better and for worse .